Literature DB >> 31123384

Pneumodissection during Percutaneous Renal Ablation Resulting in Air Embolism: Percutaneous Management and a Review of the Literature.

Kamil Arif1, Andrew J Gunn1.   

Abstract

Percutaneous renal ablation is a nephron-sparing approach for selected patients with renal cell carcinoma. Common complications include hemorrhage, injury to the urinary collecting system, and abscess formation. The purpose of this article is to present a case of vascular air embolism as a complication of pneumodissection performed during percutaneous ablation of renal cell carcinoma, discuss its successful percutaneous management, review common complications of renal ablation, and outline steps physicians can take to lessen these complications.

Entities:  

Keywords:  complications; interventional radiology; pneumodissection; renal ablation; vascular air embolism

Year:  2019        PMID: 31123384      PMCID: PMC6531020          DOI: 10.1055/s-0039-1688426

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  31 in total

1.  Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Shigeki Kobayashi; Masao Akeboshi; Haruyuki Takaki; Zentaro Kariya; Hiroyuki Kinbara; Kiminobu Arima; Makoto Yanagawa; Yasuhide Hori; Hiromi Kato; Yoshiki Sugimura; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2006 May-Jun       Impact factor: 2.740

2.  Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery.

Authors:  Vincenzo Ficarra; Giacomo Novara; Silvia Secco; Veronica Macchi; Andrea Porzionato; Raffaele De Caro; Walter Artibani
Journal:  Eur Urol       Date:  2009-08-04       Impact factor: 20.096

3.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

Review 4.  Laparoscopy: searching for the proper insufflation gas.

Authors:  T Menes; H Spivak
Journal:  Surg Endosc       Date:  2000-11       Impact factor: 4.584

5.  Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.

Authors:  Debra A Gervais; Ronald S Arellano; Francis J McGovern; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

6.  Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.

Authors:  Colin P Cantwell; Tze M Wah; Debra A Gervais; Brian H Eisner; Ronald Arellano; Raul N Uppot; Anthony E Samir; Henry C Irving; Francis McGovern; Peter R Mueller
Journal:  J Vasc Interv Radiol       Date:  2008-06-02       Impact factor: 3.464

7.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.

Authors:  Alexander Kutikov; Robert G Uzzo
Journal:  J Urol       Date:  2009-07-17       Impact factor: 7.450

Review 8.  Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.

Authors:  Hyunchul Rhim; Gerald D Dodd; Kedar N Chintapalli; Bradford J Wood; Damian E Dupuy; Julia L Hvizda; Patrick E Sewell; S Nahum Goldberg
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

9.  Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.

Authors:  Kiminobu Arima; Kouichirou Yamakado; Hiroyuki Kinbara; Atsuhiro Nakatsuka; Kan Takeda; Yoshiki Sugimura
Journal:  Int J Urol       Date:  2007-07       Impact factor: 3.369

10.  Acute management of vascular air embolism.

Authors:  Nissar Shaikh; Firdous Ummunisa
Journal:  J Emerg Trauma Shock       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.